Avigen ends gene therapy research after 12 years of little success

Email this article to a friend

Printable Version

After 12 years of research into gene therapy, Avigen has decided to end its gene therapy research and stick to traditional pharmaceuticals. Though gene therapy held a great deal of promise for curing numerous ailments, Avigen was never able to produce any proven treatments. However, they will continue clinical trials on their gene therapy for Parkinson's disease.

Avigen is expected to lay off more of its 60-person workforce, but the company may simply fold its gene therapy arm into other projects. However, this shift away from gene therapy should interest investors, as the new focus on standard drugs will cut the company's expenses considerably.
About the author: Mike Adams is a natural health author and technology pioneer with a mission to teach personal and planetary health to the public He has authored more than 1,500 articles and dozens of reports, guides and interviews on natural health topics, impacting the lives of millions of readers around the world who are experiencing phenomenal health benefits from reading his articles. Adams is an honest, independent journalist and accepts no money or commissions on the third-party products he writes about or the companies he promotes. In 2007, Adams launched EcoLEDs, a maker of energy efficient LED lights that greatly reduce CO2 emissions. He also launched an online retailer of environmentally-friendly products (BetterLifeGoods.com) and uses a portion of its profits to help fund non-profit endeavors. He's also the founder of a well known HTML email software company whose 'Email Marketing Director' software currently runs the NaturalNews subscription database. Adams is currently the executive director of the Consumer Wellness Center, a 501(c)3 non-profit, and regularly pursues cycling, nature photography, Capoeira and Pilates.


Get articles like this delivered to you FREE in our popular email newsletter

Related CounterThink Cartoons:

Related Articles: • Gene therapy and genetic engineering: the future of medicine? • FDA ready to loosen rules for clinical trials, allowing drug companies to make them up as they go along • Clinical Drug Trials: FDA Fails to Monitor Safety and Integrity	Take Action: Support NaturalNews.com Email this article to a friend Share this article on: NewsVine | digg | del.icio.us Permalink to this article: http://www.NaturalNews.com/006809_gene_therapy_clinical_trials_disease.html Reprinting this article: Non-commercial use OK, cite NaturalNews.com with clickable link. Embed article link: (copy HTML code below): <a href = "http://www.NaturalNews.com/006809_gene_therapy_clinical_trials_disease.html">Avigen ends gene therapy research after 12 years of little success</a>